Submitted by Linda McGlone
- Media Title: Cannabis Intel
- Media Type: Online
- Publish Date: 28 January 2019
- Headline: Affordable products for epilepsy patients arrives in Australia
- Abstract: MGC Pharma has also collaborated with Epilepsy Action Australia to develop C4E (cannabis for epilepsy), to provide education to epilepsy sufferers and their families on medicinal cannabis and its interaction with the illness.
- Link: https://cannabisintel.com.au/2019/01/28/affordable-products-for-epilepsy-patients-arrives-in-australia/